Trial Summary
What is the purpose of this trial?Therapeutic inertia may result from providers, patients, and/or systems, but can be detrimental to a patients' health by putting them at risk for diabetes complications, though addressing it early can mitigate some of its effects. In Type 2 diabetes (T2D) care, this may look like failure to initiate metformin therapy early in the disease course. This project aims to evaluate the effects of proactive outreach by a non-physician clinician (Accountable Population Manager \[APM\]) to patients with newly diagnosed Type 2 diabetes. The team hypothesizes individuals receiving proactive outreach by an APM will be more likely to achieve glycemic targets at 6 months following start of the intervention.
Eligibility Criteria
This trial is for adults aged 18-74 who are members of Kaiser Permanente Northern California, have recently been diagnosed with Type 2 Diabetes, and haven't started on metformin despite having an A1c level between 6.5-7.9%. Pregnant individuals or those likely to have Type 1 diabetes, or a previous diagnosis of T2D are excluded.Inclusion Criteria
I am between 18 and 74 years old and a member of Kaiser Permanente Northern California.
I have been diagnosed with Type 2 Diabetes recently.
Patient of primary care physician (PCP) working in the randomized service areas
+2 more
Exclusion Criteria
I am likely to have Type 1 diabetes.
I have been diagnosed with type 2 diabetes.
You were pregnant when you were diagnosed with type 2 diabetes.
Participant Groups
The study tests if proactive outreach by non-physician clinicians (Accountable Population Managers) can help patients newly diagnosed with Type 2 Diabetes start treatment early and reach blood sugar targets within six months.
3Treatment groups
Experimental Treatment
Active Control
Group I: Arm 3: Physician Education + Accountable Population Manager OutreachExperimental Treatment2 Interventions
Physicians in service areas randomized to this arm were invited to a physician education session on therapeutic inertia. Patients enrolled in this arm may receive proactive outreach from an Accountable Population Manager (APM).
Group II: Arm 2: Physician EducationExperimental Treatment1 Intervention
Physicians in service areas randomized to this arm were invited to a physician education session on therapeutic inertia.
Group III: Arm 1: Usual CareActive Control1 Intervention
Participants will receive standard care for newly diagnosed Type 2 Diabetes.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Kaiser Permanente Division of ResearchOakland, CA
Loading ...
Who Is Running the Clinical Trial?
Kaiser PermanenteLead Sponsor
American Diabetes AssociationCollaborator